SA Editor Douglas W. House
Healthcare, Biotech, special situations, event-driven, growth

Tengion: A Cautionary Tale For Regenerative Medicine Bulls

No narrative about the commercialization efforts of regenerative medicine would be complete without the story of Tengion (TNGN). It represents a business school-caliber case study about the risks inherent in bringing a novel medical product to market, even with an impressive pedigree, best-in-class technology, a colossal market opportunity, financial support from seasoned institutional investors and experienced personnel. Through the second quarter of this year, TNGN boasts an accumulated deficit of ~$265M, no products even remotely close to gaining regulatory clearance anywhere in the world and IPO shares that have lost 99.9% of their value in only three and a half years. The educational value of TNGN's history to biotech investors is infinitely greater than any success story could ever hope...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details